Serum Institute may face delay in Covovax launch

India’s drug regulator has asked for the immunogenicity data from Serum Institute as the vaccine is not yet appoved by the US FDA.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3yQflrm
via IFTTT